Endocrine & Metabolism Research Institute

This article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article needs additional citations for verification. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources:  –  ·  ·  · scholar · JSTOR (July 2021) (Learn how and when to remove this template message) This article relies too much on references to primary sources. Please improve this by adding secondary or tertiary sources. (July 2021) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Endocrine & Metabolism Research Institute (EMRI) (Persian: پژوهشگاه علوم غدد و متابولیسم) is one of Tehran University of Medical Sciences research institute and a pioneering institute with a mission to combine clinical care, research and education in diabetes, endocrine and metabolic diseases.

History[]

The Endocrinology and Metabolism Research Institute was established in 1993 as the Endocrinology and Metabolism Research Centre of Tehran University of Medical Sciences in Dr. Shariati Hospital Campus in Tehran. As a result of its outstanding performance, the Endocrinology and Metabolism Research Centre (EMRC) was promoted to the Endocrinology and Metabolism Research Institute (EMRI) in 2010. In 2012, the institute was officially promoted to the highest possible status of a research organization in Iran.

EMRI has been authorized as the collaborating institute for education, management, and research on osteoporosis and diabetes by the World Health Organization since 2007;.^[1]

Research Centers[]

The EMRI 's fields of interest includes, but are not limited to, diabetes, osteoporosis, endocrinology, biosensors, metabolic disorders, obesity, non communicable diseases, elderly health, chronic diseases, cell therapy and regenerative medicine, metabolomics and genomics, as well as personalized medicine. Each of the abovementioned fields of research is covered by a designated research center affiliated to EMRI.

Endocrinology and Metabolism Molecular-Cellular Sciences Institute[]

• Biosensor Research Center
• Metabolic Disorders Research Center
• Obesity and Eating Habits Research Center
• Metabolomics and genomics research center
• Cell therapy and regenerative medicine research center

Endocrinology and Metabolism Clinical Sciences Institute[]

• Diabetes Research Center
  • Diabetes Research Centre was established in 2010 in Endocrinology and Metabolism Research Institute. the main activities of the Diabetes Research Center are focused on the sciences related to diabetes new treatment methods including cell therapy and pancreatic transplantation, diabetic foot and gestational diabetes. the most important achievement of the Diabetes Research Center is the production of AngiPars drug for the treatment of diabetic foot ulcers.^[2]
• Osteoporosis Research Center
  • (ORC) is one of the 13 centers affiliated to Endocrinology and Metabolism Research Institute and was established in 2010 to provide the necessary evidence in the field of osteoporosis at the national and international levels. Currently the ORC collaborate to the World Health Organization since 2010 to 2024^[3] and the International Osteoporosis Foundation.^[4]
• Endocrinology and Metabolism Research Center
• Personalized Medicine Research Center
• Evidence-Based Medicine Research Center

Endocrinology and Metabolism Population Sciences Institute[]

• Chronic Diseases Research Center
• Elderly Health Research Center
• Non-Communicable Diseases Research Center

International Collaboration[]

World Health Organization[]

Endocrinology and Metabolism Research Institute is WHO Collaborating Center since 2007 in "Research and Education on Management of Osteoporosis and Diabetes".^[1]

Collaboration Terms of Reference[]

• To support WHO in its work towards reduction and early screening of diabetes, osteoporosis and their complications, through training and capacity building;
• To support WHO to monitor and evaluate Sustainable Development Goals (SDGs) through a systematic effort on data collecting, processing and developing analytical models.^[1][3]

International Osteoporosis Organization[]

Endocrinology and Metabolism Research Institute has been an active member of IOF, since 2004.EMRI has been involved in raising public awareness and improving professional education by different means such as organizing national and international events, establishment of Osteoporosis Research Center within the institute.^[5][4]

Achievements and Awards[]

Achievements[]

• Partner in Horizon 2020 Framework Programme of the European Union for the Project entitled, "PoC in-office device for identifying individuals at high risk of osteoporosis and osteoporotic fracture";^[6] (Project website)
• The development of a new drug for patients with diabetic foot: ™;^[2][7]
• Collaboration with International Osteoporosis Foundation since 2004;^[3]
• Collaborating Center of World Health Organization since 2007;^[4]

Awards[]

1. , The Best Research center, 2010, 2011, 2012, 2013, 2014, 2016, 2017, 2018, and 2019;
2. UN Interagency Task Force on the Prevention and Control of NCDs award, 2018;^[8]
3. IOF Committee of National Societies Medal, 2018 ^[9]
4. Gold Circle Diabetes Award (IBDO-Italy), 2017;
5. Avicenna Medical Research Award, Medical Ethics Awards, Best Research Project Award, 2013;
6. World Health Organization, Prize for the Control of Cancer, Cardiovascular Disease and Diabetes in the Eastern Mediterranean 2010.

References[]

External links[]

• Official Website (English Website)
• Official Website (Persian Website)